http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109266579-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-11 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-11 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate | 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109266579-B |
titleOfInvention | Bacillus megaterium and application thereof |
abstract | The invention discloses bacillus megaterium and application thereof, and belongs to the technical field of asymmetric synthesis of chiral compounds by a biological method. The Bacillus megaterium BM1-1 is subjected to activation, strain culture, enrichment and lean culture medium culture, and cells catalytically degrade acetophenone in the absence of energy sources. The invention determines a reaction system and conditions for carrying out the complete cell catalytic degradation of the acetophenone by using the strain. The method is convenient to operate, has good industrial application prospect in the fields of degrading acetophenone by biocatalysis and preparing duloxetine, and has important significance for developing a special biocatalyst for biocatalysis and researching a chiral drug synthesis method in the future. |
priorityDate | 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.